Day: October 2, 2020

Uncategorized

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder total information

  Major depressive disorder (MDD) is highly prevalent and frequently disabling. Only about 30% of patients respond to a first-line antidepressant treatment, and around 30% of patients are classified as “treatment-resistant” after failing to respond to multiple adequate trials. While most antidepressants target monoaminergic targets, ketamine is an N-methyl-D-aspartate (NMDA) antagonist that has shown rapid […]

Read More